These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22321874)

  • 1. Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men.
    Pelletier-Beaumont E; Arsenault BJ; Alméras N; Bergeron J; Tremblay A; Poirier P; Després JP
    Atherosclerosis; 2012 Apr; 221(2):577-82. PubMed ID: 22321874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
    Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: results from a 1-year lifestyle intervention in viscerally obese men.
    Gangloff A; Bergeron J; Pelletier-Beaumont E; Nazare JA; Smith J; Borel AL; Lemieux I; Tremblay A; Poirier P; Alméras N; Després JP
    Int J Obes (Lond); 2015 Nov; 39(11):1638-43. PubMed ID: 26095245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
    Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Metabolism; 2012 Feb; 61(2):262-72. PubMed ID: 21864868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCSK9 levels in abdominally obese men: association with cardiometabolic risk profile and effects of a one-year lifestyle modification program.
    Arsenault BJ; Pelletier-Beaumont E; Alméras N; Tremblay A; Poirier P; Bergeron J; Després JP
    Atherosclerosis; 2014 Oct; 236(2):321-6. PubMed ID: 25128757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adipose tissue accumulation, secretory phospholipase A2-IIA and atherogenecity of LDL.
    Paradis ME; Hogue MO; Mauger JF; Couillard C; Couture P; Bergeron N; Lamarche B
    Int J Obes (Lond); 2006 Nov; 30(11):1615-22. PubMed ID: 16534517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors.
    Di Marzo V; Côté M; Matias I; Lemieux I; Arsenault BJ; Cartier A; Piscitelli F; Petrosino S; Alméras N; Després JP
    Diabetologia; 2009 Feb; 52(2):213-7. PubMed ID: 18972095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle modification decreases arterial stiffness and plasma asymmetric dimethylarginine level in overweight and obese men.
    Maeda S; Miyaki A; Kumagai H; Eto M; So R; Tanaka K; Ajisaka R
    Coron Artery Dis; 2013 Nov; 24(7):583-8. PubMed ID: 23881175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adiposity and apolipoprotein C-III in apolipoprotein B-containing lipoproteins are independent predictors in determining atherogenic lipid profiles.
    Han T; Woo SK; Shin S; Kang HS
    Ann Nutr Metab; 2006; 50(1):31-6. PubMed ID: 16276073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure.
    Onat A; Ayhan E; Hergenç G; Can G; Barlan MM
    Metabolism; 2009 Jul; 58(7):963-70. PubMed ID: 19411085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate-to-vigorous physical activity with accelerometry is associated with visceral adipose tissue in adults.
    Murabito JM; Pedley A; Massaro JM; Vasan RS; Esliger D; Blease SJ; Hoffman U; Fox CS
    J Am Heart Assoc; 2015 Mar; 4(3):e001379. PubMed ID: 25736442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet-induced Fasting Ghrelin Elevation Reflects the Recovery of Insulin Sensitivity and Visceral Adiposity Regression.
    Tsaban G; Yaskolka Meir A; Zelicha H; Rinott E; Kaplan A; Shalev A; Katz A; Brikner D; Blüher M; Ceglarek U; Stumvoll M; Stampfer MJ; Shai I
    J Clin Endocrinol Metab; 2022 Jan; 107(2):336-345. PubMed ID: 34643713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
    Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
    Després JP; Ross R; Boka G; Alméras N; Lemieux I;
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial.
    Gepner Y; Shelef I; Schwarzfuchs D; Zelicha H; Tene L; Yaskolka Meir A; Tsaban G; Cohen N; Bril N; Rein M; Serfaty D; Kenigsbuch S; Komy O; Wolak A; Chassidim Y; Golan R; Avni-Hassid H; Bilitzky A; Sarusi B; Goshen E; Shemesh E; Henkin Y; Stumvoll M; Blüher M; Thiery J; Ceglarek U; Rudich A; Stampfer MJ; Shai I
    Circulation; 2018 Mar; 137(11):1143-1157. PubMed ID: 29142011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic exercise training reduces epicardial fat in obese men.
    Kim MK; Tomita T; Kim MJ; Sasai H; Maeda S; Tanaka K
    J Appl Physiol (1985); 2009 Jan; 106(1):5-11. PubMed ID: 18927266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity.
    Han SJ; Fujimoto WY; Kahn SE; Leonetti DL; Boyko EJ
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):351-358. PubMed ID: 32615719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk.
    Onat A; Avci GS; Barlan MM; Uyarel H; Uzunlar B; Sansoy V
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1018-25. PubMed ID: 15197408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.
    Borel AL; Nazare JA; Baillot A; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E273-E281. PubMed ID: 28028035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.
    Boyer M; Mitchell PL; Poirier P; Alméras N; Tremblay A; Bergeron J; Després JP; Arsenault BJ
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E460-E468. PubMed ID: 29870675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.